drugset / Trial / NCT03830034

Amino Acid Chelated Iron Versus Ferrous Fumarate in the Treatment of Iron Deficiency Anemia With Pregnancy: Randomized Controlled Trial

NCT03830034

Phase 4 Unknown 150 enrolled Ain Shams University
RandomizedParallel-groupSingle-blindTreatment

Summary

Anemia is the commonest hematological disorder that occurs in pregnancy. According to the recent standard laid down by 'WHO', anemia is present when the Hemoglobin (Hb) concentration in the peripheral blood is 11 gm/dl or less. The most common cause of anemia in pregnancy is lack of iron. This study is done to compare the efficacy and tolerability of iron amino acid chelate and that of iron salts (ferrous fumarat).

Timeline

Start
2019-02-02
Primary completion
2019-10-15
Completion
2019-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Amino Acid chelated iron Unknown 15 mg Oral
Comparator Ferrous Sulfate Diagnostic / imaging agent 350 mg Oral